Forza Atomics II, LP has made a significant move by filing a new offering under the Investment Company Act on October 29, 2026. This filing is crucial as it marks the company's intent to expand its investment activities and engage with potential investors.
Background
Forza Atomics II, LP, a limited partnership incorporated in Delaware, operates in the pooled investment fund sector. The firm is based in Summit, New Jersey, and focuses on private equity investments. The recent filing is part of its ongoing strategy to attract capital and manage investments effectively.
What the Filing Says
The SEC filing indicates that Forza Atomics II, LP is utilizing exemptions under Section 3(c) and 3(c)(1) of the Investment Company Act. The filing states, "The Investment Manager receives customary management fees," which suggests a structured approach to managing investor contributions.
Impact
This offering may impact various stakeholders, including the seven investors already involved with the fund. With a total amount sold of approximately $2.5 million, the filing indicates that the company is poised for growth, potentially attracting more accredited investors in the private equity landscape.
What's Next
The filing does not say what happens next.
Investment Details
The filing reveals that the total offering amount is classified as indefinite, indicating that Forza Atomics II, LP plans to raise capital over an unspecified period. As of the date of the filing, the total amount sold stands at approximately $2,535,663, with a total of seven investors already participating in the fund.
Management and Leadership
Mark Melchiorre is identified as the Managing Member of the General Partner, holding multiple roles within the company, including Executive Officer and Director. His involvement suggests a strong leadership presence in guiding the firm's investment strategies and operations.
Offering Structure
Forza Atomics II, LP is structured as a private equity fund under the pooled investment fund category. The offering does not include any sales commissions or finders fees, which may indicate a direct approach to investor relations without intermediary costs.
Regulatory Compliance
The filing confirms that the company is utilizing exemptions under Section 3(c) and 3(c)(1) of the Investment Company Act, which allows it to operate without registering as an investment company, provided it meets certain criteria regarding investor qualifications and the nature of its offerings.
Future Considerations
While the filing provides substantial information about the current offering and operational framework, it does not specify the anticipated timeline for future fundraising efforts or any planned changes in investment strategy.
Read Next
Workers United Files to Sell $8.4 Million in Amalgamated Stock
Carvana Co. files to sell 10 million shares of stock
Platford Giles Richard to Sell 55,617 Takeda Shares
Takeda's Teresa Bitetti to Sell 46,609 Shares Amid Tax Obligations
Kiniksa Pharmaceuticals reports significant stock sale by officer
Moat Ross to Sell Over 103,000 Shares of Kiniksa Pharmaceuticals










